日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing.

经基因工程改造可分泌双特异性抗体的人类浆细胞可有效杀灭体内白血病细胞

Hill Tyler F, Narvekar Parnal, Asher Gregory D, Edelstein Jasmine N, Camp Nathan D, Grimm Annaiz, Thomas Kerri R, Leiken Michael D, Molloy Katherine M, Cook Peter J, Arlauckas Sean P, Morgan Richard A, Tasian Sarah K, Rawlings David J, James Richard G

Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing

经基因工程改造可分泌双特异性抗体的人类浆细胞,能够有效杀伤体内白血病细胞。

Hill, Tyler F; Narvekar, Parnal; Asher, Gregory; Camp, Nathan; Thomas, Kerri R; Tasian, Sarah K; Rawlings, David J; James, Richard G

Correction: CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets

更正:CCR7 提供局部途径获取 IL-2,并定义稳态上不同的调节性 T 细胞亚群。

Smigiel, Kate S; Richards, Elizabeth; Srivastava, Shivani; Thomas, Kerri R; Dudda, Jan C; Klonowski, Kimberly D; Campbell, Daniel J